Valneva SE

VALN

Healthcare|Biotechnology|FR

$5.51

-0.13 (-2.30%)

Tangible Book / Share

$0.63

Cash / Share

$1.28

Next Earnings Report

Nov 24, 2026

EPS est. -$0.23 · Revenue est. $43.7M

Financing Filings (last 12 months)

Shelf registrations / offering prospectuses — latest Jun 16, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (1)

Jun 2027

Est. completion

P4Chikungunya Virus Infection

Real-world Effectiveness, Safety & Immunogenicity of Chikungunya Vaccination: Ambispective Study in Reunion & French Guiana

NCT06928753n=1,505

Awaiting Results (3)

Trials past primary completion date but still active — data readout may be imminent.

Oct 2026

Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

NCT07254702

Jul 2026

Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

NCT07163845

Mar 2023

Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)

NCT04838444

Recent Press Releases

Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026

Nov 4, 2026 · GlobeNewsWire

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Oct 14, 2026 · GlobeNewsWire

Valneva Provides Update on IXCHIQ® in the United Kingdom

Oct 7, 2026 · GlobeNewsWire

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Aug 14, 2026 · GlobeNewsWire

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Aug 14, 2026 · Business Wire

Valneva publie ses résultats financiers du premier semestre 2026 et fait un point sur ses activités

Aug 13, 2026 · Globe News Wire

Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates

Aug 13, 2026 · GlobeNewsWire

SEC Filings (78)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

Filed	Form	What it is	Links
Nov 6, 2026	6-K	Foreign issuer report	Document Index
Oct 15, 2026	6-K	Foreign issuer report	Document Index
Oct 8, 2026	6-K	Foreign issuer report	Document Index
Aug 14, 2026	6-K	Foreign issuer report	Document Index
Aug 13, 2026	6-K	Foreign issuer report	Document Index
Jul 22, 2026	6-K	Foreign issuer report	Document Index
Jun 25, 2026	6-K	Foreign issuer report	Document Index
Jun 16, 2026	EFFECT		Document Index
Jun 16, 2026	424B3	Offering prospectus	Document Index
Jun 5, 2026	6-K	Foreign issuer report	Document Index
Jun 4, 2026	F-3	Shelf registration	Document Index
Jun 1, 2026	6-K	Foreign issuer report	Document Index
May 13, 2026	6-K	Foreign issuer report	Document Index
May 12, 2026	SC 13D/A	Activist / 5%+ stake	Document Index
May 12, 2026	SC 13G	Passive 5%+ stake	Document Index
May 5, 2026	6-K	Foreign issuer report	Document Index
Apr 30, 2026	6-K	Foreign issuer report	Document Index
Mar 26, 2026	6-K	Foreign issuer report	Document Index
Mar 23, 2026	6-K	Foreign issuer report	Document Index
Mar 18, 2026	6-K	Foreign issuer report	Document Index
Mar 17, 2026	20-F	Annual report (foreign)	Document Index
Mar 10, 2026	SC 13D/A	Activist / 5%+ stake	Document Index
Mar 9, 2026	6-K	Foreign issuer report	Document Index
Mar 2, 2026	6-K	Foreign issuer report	Document Index
Feb 19, 2026	6-K	Foreign issuer report	Document Index
Feb 13, 2026	6-K	Foreign issuer report	Document Index
Feb 3, 2026	6-K	Foreign issuer report	Document Index
Jan 20, 2026	6-K	Foreign issuer report	Document Index
Jan 9, 2026	6-K	Foreign issuer report	Document Index
Dec 31, 2025	6-K	Foreign issuer report	Document Index
Dec 11, 2025	6-K	Foreign issuer report	Document Index
Nov 28, 2025	6-K	Foreign issuer report	Document Index
Nov 26, 2025	6-K	Foreign issuer report	Document Index
Nov 20, 2025	6-K	Foreign issuer report	Document Index
Nov 4, 2025	6-K	Foreign issuer report	Document Index
Oct 6, 2025	6-K/A	Foreign issuer report	Document Index
Oct 6, 2025	6-K	Foreign issuer report	Document Index
Oct 6, 2025	6-K	Foreign issuer report	Document Index
Sep 5, 2025	SC 13D/A	Activist / 5%+ stake	Document Index
Sep 3, 2025	6-K	Foreign issuer report	Document Index